Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02572882 · ClinicalTrials.gov registry record · NA
Gut Microbiome and p-Inulin in Hemodialysis
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT02572882: Completed NA study, sponsored by University of Pennsylvania.
NCT02572882 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02572882, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The Microbiome trial is a non-randomized, open-label, sequential, multi-center study of p-inulin for patients with hemodialysis-dependent end-stage renal disease.
Interventions
- DIETARY_SUPPLEMENT p-inulin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-10 |
| Est. Completion | 2019-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02572882
The ClinicalTrials.gov registry entry for NCT02572882 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which p-inulin is the first listed.
NCT02572882 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02572882 about?
NCT02572882 is a clinical study titled "Gut Microbiome and p-Inulin in Hemodialysis". The Microbiome trial is a non-randomized, open-label, sequential, multi-center study of p-inulin for patients with hemodialysis-dependent end-stage renal disease.
What is the current status of trial NCT02572882?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2015-10. Estimated completion is 2019-01.
What interventions are being tested in trial NCT02572882?
The interventions under investigation include: p-inulin (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02572882?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.